Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 13, Issue 4, 2014, Pages 478-484

  Leclercq, A ^a   Gauthier, B ^b   Rosner, V ^a   Weiss, L ^a   Moreau, F ^a   Constantinescu, A A ^c,d   Kessler, R ^a   Kessler, L ^a,c  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY OF AGRONOMIC SCIENCES AND VETERINARY MEDICINE OF BUCHAREST   (Romania)

Author keywords

CGM; Cystic fibrosis; Early glucose tolerance abnormalities; Lung function; OGTT

Indexed keywords

ANTIBIOTIC AGENT; GLUCOSE; HEMOGLOBIN A1C; PREALBUMIN; GLUCOSE BLOOD LEVEL; INSULIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LUNG FUNCTION; MALE; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPIROMETRY; STAPHYLOCOCCUS AUREUS; ADOLESCENT; ADULT; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; FOLLOW UP; FRANCE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; LUNG DISEASES; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; FRANCE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LUNG DISEASES; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREVALENCE; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; YOUNG ADULT;

EID: 84902306654     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.11.005     Document Type: Article

References (31)

1. Moran A., Brunzell C., Cohen R.C., Katz M., Marshall B.C., Onady G., et al. CFRD Guidelines Committee. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010, 33:2697-2708.
2. Milla C.E., Warwick W.J., Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000, 162:891-895.
3. Kerem E., Viviani L., Zolin A., Macneill S., Hatziagorou E., Ellemunter H., et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the data of the ECFS Patient Registry. Eur Respir J 2013, [Epub ahead of print]. 10.1183/09031936.00166412.
4. Lanng S., Thorsteinsson B., Nerup J., Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992, 151:684-687.
5. Moran A., Dunitz J., Nathan B., Saeed A., Holme B., Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009, 32:1626-1631.
6. Salvatore D., Buzzetti R., Baldo E., Forneris M.P., Lucidi V., Manunza D., et al. An overview of international literature from cystic fibrosis registries: 2. Neonatal screening and nutrition/growth. J Cyst Fibros 2010, 9:75-83.
7. Chamnan P., Shine B.S., Haworth C.S., Bilton D., Adler A.I. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 2010, 33:311-316.
8. Dobson L., Sheldon C.D., Hattersley A.T. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004, 21:691-696.
9. Ode K.L., Frohnert B., Laguna T., Phillips J., Holme B., Regelmann W., et al. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes 2010, 11:487-492.
10. Costa M., Potvin S., Hammana I., Malet A., Berthiaume Y., Jeanneret A., et al. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 2007, 6:376-383.
11. Hameed S., Morton J.R., Jaffé A., Field P.I., Belessis Y., Yoong T., et al. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care 2010, 33:221-226.
12. Battelino T., Conget I., Olsen B., Schütz-Fuhrmann I., Hommel E., Hoogma R., et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012, 55:3155-3162.
13. Floyd B., Chandra P., Hall S., Phillips C., Alema-Mensah E., Strayhorn G., et al. Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. J Diabetes Sci Technol 2012, 6:1094-1102.
14. Danne T., de Valk H.W., Kracht T., Walte K., Geldmacher R., Sölter L., et al. Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology. Diabetologia 2009, 52:1496-1503.
15. O'Riordan S.M., Hindmarsh P., Hill N.R., Matthews D.R., George S., Greally P., et al. Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study. Diabetes Care 2009, 32:1020-1022.
16. Dobson L., Sheldon C.D., Hattersley A.T. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 2003, 26:1940-1941.
17. Moreau F., Weiller M.A., Rosner V., Weiss L., Hasselmann M., Pinget M., et al. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res 2008, 40:502-506.
18. Franzese A., Valerio G., Buono P., Spagnuolo M.I., Sepe A., Mozzillo E., et al. Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. J Pediatr Endocrinol Metab 2008, 21:109-116.
19. Schiaffini R., Brufani C., Russo B., Fintini D., Migliaccio A., Pecorelli L., et al. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. Eur J Endocrinol 2010, 162:705-710.
20. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: diagnosis and classification of diabetes mellitus. Diabet Med 1998, 15:539-553.
21. Rolland-Cachera M.F., Cole T.J., Sempé M., Tichet J., Rossignol C., Charraud A. Body mass index variations: centiles from birth to 87years. Eur J Clin Nutr 1991, 45:13-21.
22. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
23. Saiman L., Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003, 24:S6-S52. Cystic Fibrosis Foundation.
24. Hillman M., Eriksson L., Mared L., Helgesson K., Landin-Olsson M. Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus. J Cyst Fibros 2012, 11:144-149.
25. Mohan K., Miller H., Dyce P., Grainger R., Hughes R., Vora J., et al. Mechanisms of glucose intolerance in cystic fibrosis. Diabet Med 2009, 26:582-588.
26. Khammar A., Stremler N., Dubus J.C., Gross G., Sarles J., Reynaud R. Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis. Arch Pediatr 2009, 16:1540-1546.
27. Wagener J.S., McNeill G.C., Taussig L.M., Corrigan J.J., Lemen R. Ferrokinetic and hematologic studies in cystic fibrosis patients. Am J Pediatr Hematol Oncol 1983, 5:153-160.
28. Pistrosch F., Koehler C., Wildbrett J., Hanefeld M. Relationship between diurnal glucose levels and HbA1c in type 2 diabetes. Horm Metab Res 2006, 38:455-459.
29. Monnier L., Colette C. Contributions of fasting and postprandial glucose to hemoglobin A1c. Endocr Pract 2006 Jan-Feb, 12(Suppl. 1):42-46.
30. Alicandro G., Battezzati P.M., Battezzati A., Speziali C., Claut L., Motta V., et al. Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance. Clin Nutr 2012, 31:118-123.
31. Brennan A.L., Gyi K.M., Wood D.M., Johnson J., Holliman R., Baines D.L., et al. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2007, 6:101-109.